Goss Wealth Management »

Monopar Therapeutics shares owned by Goss Wealth Management

Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by Goss Wealth Management from 13F filings

Historical chart of Goss Wealth Management investment in Monopar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monopar Therapeutics held by Goss Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monopar Therapeutics by Goss Wealth Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.2k 3.0k 0.73
2024-03-31 $2.0k 3.0k 0.68

More positions owned by Goss Wealth Management

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Amazon (AMZN)
Broadcom (AVGO)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr S&p 500 Grwt Etf (IVW)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Spdr Ser Tr Portfolio S&p500 (SPLG)

View all positions for Goss Wealth Management

Top funds holding Monopar Therapeutics

Millennium Management
Geode Capital Management
Two Sigma Securities
Vanguard Group
Gerber
Virtu Financial
Rappaport Reiches Capital Management
Tower Research Capital
FMR
Goss Wealth Management
UBS Group
Wells Fargo & Company
Bank of America Corporation
Federation des caisses Desjardins du Quebec

View all funds holding Monopar Therapeutics